地舒单抗与 RANKL 受体抑制剂：疗效更佳
However, overall, both denosumab and other RANKL receptor inhibitors it represents have better efficacy, whether compared in terms of comparing single drugs or classifying drugs based on mechanisms.
原文地址: https://www.cveoy.top/t/topic/o6YA 著作权归作者所有。请勿转载和采集!